Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration

首次发布于 2014 年 1 月 15 日

Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

计划入组 26 人 · 首次发布于 2020 年 7 月 31 日

Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg

计划入组 120 人 · 首次发布于 2008 年 4 月 1 日

Canada Association

ARAC

Aquinox Pharmaceuticals (Canada), Inc.

Canada

NOVARTIS PHARMACEUTICALS CORPORATION

United States

NOVARTIS PHARMACEUTICALS (HK) LIMITED

Hong Kong, China

Novartis Secures Pan-Canadian Agreement for Leqvio Access in Familial Hypercholesterolemia

Novartis Canada and SP Quebec Mark 16 Years of Partnership with MS Tri-Challenge, Surpassing $650,000 CAD in Fundraising

Novartis Secures Canadian Public Reimbursement for Cosentyx in Hidradenitis Suppurativa